Le Lézard
Classified in: Health

Canada Life adds Dialogue's iCBT to Consult+ for all plan members


Canada Life is the first national insurer in Canada to include Dialogue's iCBT as part of their standard virtual healthcare offering.

WINNIPEG, MB and MONTREAL, Dec. 2, 2021 /CNW/ - The Canada Life Assurance Company ("Canada Life") and Dialogue Health Technologies Inc. (TSX: CARE) ("Dialogue") jointly announce that, effective today, Dialogue's internet-based cognitive behavioural therapy (iCBT) program will be made available to all Consult+ users across Canada.

Mental health issues are rising in and outside the workplace, making innovative mental health support options highly necessary. According to Statistics Canada, 23 per cent of Canadians with unmet mental health needs prefer to manage their mental health on their own.

"The past 20 months have been challenging for many Canadians, especially when it comes to their mental health ? many continue to struggle," said Brad Fedorchuk, Executive Vice-President, Group Customer, Canada Life. "Through Dialogue's iCBT, plan members can access self-led mental health support for mild to moderate depression and anxiety. By taking a proactive approach to their well-being, they'll be better positioned to reach their full potential."

iCBT uses similar principles and techniques as in-person cognitive behavioural therapy programs, but is delivered in a structured digital format consisting of educational material and interactive toolkits.

"This partnership with Canada Life will allow Canadians to access mental health support when they need it," said Jean-Nicolas Guillemette, Chief Operating Officer of Dialogue. "This added offering reinforces the strong relationship between Canada Life and Dialogue. With the increase of mental health concerns across all organizations and industries, we are proud to keep working towards bringing innovative health and well-being solutions to millions of Canadians."

Earlier this year, Dialogue completed the acquisition of ehub Health, a mental health provider and leader in iCBT.

About Dialogue

Incorporated in 2016, Dialogue is Canada's premier virtual healthcare and wellness platform, providing affordable, on-demand access to quality care. Through our team of health professionals, we serve employers and organizations who have an interest in the health and well-being of their employees, members and their families. Our Integrated Health Platformtm is a one-stop healthcare hub that centralizes all of our programs in a single, user-friendly application, providing access to services 24 hours per day, 365 days per year from the convenience of a smartphone, computer or tablet.

About The Canada Life Assurance Company

Canada Life is a leading insurance, wealth management and benefits provider focused on improving the financial, physical and mental well-being of Canadians. For more than 170 years, individuals, families and business owners across Canada have trusted us to provide sound guidance and deliver on the promises we've made

On January 1, 2020, Great-West Life, London Life and Canada Life became one company ? Canada Life, and today, we proudly serve more than 12 million customer relationships from coast to coast to coast. Follow us on Facebook, Twitter, Instagram, YouTube and LinkedIn.

SOURCE Dialogue Health Technologies Inc.


These press releases may also interest you

at 08:03
The American Red Cross celebrates The Church of Jesus Christ of Latter-day Saints, headquartered in Salt Lake City, for its substantial donation of $7.35 million. The gift will help purchase blood equipment and biomedical emergency vehicles and will...

at 08:00
A Canada-wide Settlement Agreement was recently reached in a class action against Cook (Canada) Inc., Cook Incorporated, and William Cook Europe APS ("Cook") related to certain inferior vena cava filter products ("IVC Filter Products") marketed and...

at 08:00
Alebund Pharmaceuticals ("Alebund" or the "Company"), an integrated biopharmaceutical company focusing on developing innovative therapies for the treatment of renal diseases and related chronic conditions, announced today that the US Food and Drug...

at 08:00
Key Proteo, a pioneering proteomics diagnostics company specializing in the enhanced early detection of rare but treatable genetic disorders, today announced that it has submitted a de novo classification request to the U.S. Food and Drug...

at 08:00
Human Immunology Biosciences (HI-Biotm), a clinical-stage biotechnology company developing targeted therapies for patients with severe immune-mediated diseases (IMDs), today announced that two abstracts have been accepted for oral presentation at the...

at 08:00
PassPort Technologies, Inc. (PPTI), based in San Diego, a clinical-stage drug and medical device development company, today announced positive interim results from the Phase 1 (Part A) clinical trial of Zolmitriptan PassPort® utilizing its...



News published on and distributed by: